Objective: Smoking is a strong independent risk factor for peripheral arterial disease (PAD) incidence and quitting is a key factor of the disease evolution. This study aimed to describe the characteristics of smokers with PAD included in the French smoking cessation services (SCS) database CDTnet, as well as to identify factors associated with their abstinence. We hypothesized that certain PAD smokers' characteristics would influence quit rates.
Methods: This retrospective cohort analysis included adult smokers with PAD who were registered in CDTnet between 2001 and 2018 and who had completed at least 28 days of follow-up in SCS. One-month self-reported abstinence was confirmed by exhaled carbon monoxide < 5 ppm. Descriptive and logistic analysis were performed.
Results: Among the 3 656 smokers with PAD included in CDTnet, 76% were male, with a median age of 57 years, who mainly were hospital-referred. They presented a severe smoking profile. Indeed, half of them (48%) smoked >20 cigarettes per day, 65% presented high nicotine dependence and 30% had never quit previously. Among the sample, 46% stopped smoking at least one month. Factors favoring abstinence were: at least one previous quit attempt, a high confidence in quitting, an increasing number of follow-up visits and the prescription of nicotine patches associated or not to nicotine oral forms as well as the prescription of varenicline at the first visit.
Conclusion: Quitting smoking is reachable for PAD patients with an intensive management consisting of the prescription of a smoking cessation pharmacological treatment and a follow-up in SCS.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jvs.2025.03.002 | DOI Listing |
Nicotine Tob Res
March 2025
Center for Tobacco Research and Intervention, University of Wisconsin Madison School of Medicine and Public Health, 1930 Monroe St #200, Madison, WI 53711.
Introduction: Certain psychiatric populations have especially low smoking cessation rates. This highlights the need to identify smoking treatments that increase cessation rates by addressing factors thought to impede their success. Behavioral activation (BA) targets anhedonia (i.
View Article and Find Full Text PDFFront Psychiatry
February 2025
Respiratory Failure Unit, G. Papanikolaou Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Background: Adolescent smoking is a significant public health concern, as early nicotine addiction leads to more severe addiction and reduced cessation success during adulthood. While nicotine replacement therapy (NRT) is an effective smoking cessation tool in adults, its efficacy in adolescents is less clear.
Objective: This systematic review evaluates the effectiveness and safety of NRT for smoking cessation in adolescents.
EXCLI J
January 2025
University of Bordeaux, Inserm, Bordeaux Population Health Research Center, team HEALTHY, UMR 1219, Bordeaux, France.
The use of psychoactive products by young adults is usually described as part of their exploratory identity development. This behavior is facilitated by social and structural contexts where these substances are perceived as legal and easily accessible. While the motivations for initiating and continuing the use of tobacco and alcohol are well-documented, the same cannot be said for e-cigarettes.
View Article and Find Full Text PDFBMC Public Health
March 2025
The Comprehensive Breast Care Center, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Background: Smoking is a well-documented risk factor for numerous chronic diseases, and cessation is correlated with enhanced health outcomes. Nonetheless, the precise effects of smoking cessation on the health status of older adults with chronic conditions in China have not been thoroughly quantified.
Objective: This study aims to quantitatively assess the correlations between smoking cessation and enhancements in the health outcomes of elderly Chinese individuals with chronic diseases.
Cardiovasc Intervent Radiol
March 2025
Department of Radiology and Biomedical Imaging, Section of Interventional Radiology, Yale School of Medicine, 330 Cedar Street, TE-2, New Haven, CT, USA.
Purpose: Evaluate safety and efficacy of lung cancer cryoablation in patients with stereotactic body radiation therapy (SBRT) recurrence.
Materials And Methods: Between 9/2018 and 11/2023, all patients with non-small cell lung cancer (NSCLC) treated with lung cryoablation after SBRT recurrence were retrospectively identified. Histories of smoking, COPD, post-procedural pneumothorax, adverse events requiring immediate post-procedural hospitalization, and initiation/worsening of home oxygen requirements 3-6 months later were obtained.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!